BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 10505665)

  • 21. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
    Castro-Chaves P; Leite-Moreira AF
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.
    Kurdi M; De Mello WC; Booz GW
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1357-67. PubMed ID: 15833268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
    Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging concepts in antihypertensive therapy: the benefits of angiotensin II blockade.
    Meggs LG; Kodali P
    J Assoc Acad Minor Phys; 1999; 10(2):34-43. PubMed ID: 10826007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CNS renin-angiotensin system.
    von Bohlen und Halbach O; Albrecht D
    Cell Tissue Res; 2006 Nov; 326(2):599-616. PubMed ID: 16555051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells.
    Castoldi G; Redaelli S; van de Greef WM; di Gioia CR; Busca G; Sperti G; Stella A
    Clin Sci (Lond); 2005 Jun; 108(6):523-30. PubMed ID: 15667337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new look at the renin-angiotensin system--focusing on the vascular system.
    Nguyen Dinh Cat A; Touyz RM
    Peptides; 2011 Oct; 32(10):2141-50. PubMed ID: 21945916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
    Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
    Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia.
    Dinh DT; Frauman AG; Somers GR; Ohishi M; Zhou J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2002 Feb; 196(2):213-9. PubMed ID: 11793373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK; Williams GH
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system.
    Silva PM
    Rev Port Cardiol; 2010 May; 29(5):801-24. PubMed ID: 20866008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II and the vascular phenotype in hypertension.
    Savoia C; Burger D; Nishigaki N; Montezano A; Touyz RM
    Expert Rev Mol Med; 2011 Mar; 13():e11. PubMed ID: 21450123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonists of the renin-angiotensin system and the prevention of obesity.
    Weisinger RS; Begg DP; Jois M
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1069-77. PubMed ID: 19777395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The uteroplacental renin-angiotensin system: a review.
    Hagemann A; Nielsen AH; Poulsen K
    Exp Clin Endocrinol; 1994; 102(3):252-61. PubMed ID: 7995347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The renin-angiotensin system. New concepts in regulation of blood pressure and renal function.
    Goldfarb DA
    Urol Clin North Am; 1994 May; 21(2):187-94. PubMed ID: 8178386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control.
    Dzau VJ
    J Hypertens Suppl; 1988 Dec; 6(3):S7-12. PubMed ID: 3066879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin-angiotensin system in elasmobranch fish: A review.
    Hazon N; Tierney ML; Takei Y
    J Exp Zool; 1999 Oct; 284(5):526-34. PubMed ID: 10469990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications.
    Bottari SP; de Gasparo M; Steckelings UM; Levens NR
    Front Neuroendocrinol; 1993 Apr; 14(2):123-71. PubMed ID: 8486206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue renin-angiotensin systems: fact or fiction?
    Unger T; Gohlke P; Paul M; Rettig R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S20-5. PubMed ID: 1725037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.